Starling Oncology (STLN) Capital Expenditures Growth (1y) (2022 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Capital Expenditures Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | 4.68% |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | -12.95% |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 40.41% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 40.24% |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | -14.43% |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 6.52% |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | -1.80% |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | 461.49% |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | -37.90% |
| 10 | Starling Oncology | 609.95 Mn | 568.85 Mn | 27.17 Mn | -24.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.83% |
| Mar 31, 2026 | 217.68% |
| Dec 31, 2025 | -39.60% |
| Sep 30, 2025 | 250.25% |
| Jun 30, 2025 | -33.84% |
| Mar 31, 2025 | -46.23% |
| Dec 31, 2024 | 103.83% |
| Sep 30, 2024 | -143.23% |
| Jun 30, 2024 | 94.88% |
| Mar 31, 2024 | -66.83% |
| Dec 31, 2023 | -56.84% |
| Sep 30, 2023 | -21.85% |
| Jun 30, 2023 | -30.18% |
| Mar 31, 2023 | 83.53% |
| Dec 31, 2022 | 129.05% |
| Sep 30, 2022 | 25.26% |
| Jun 30, 2022 | 229.73% |
| Mar 31, 2022 | 61.87% |